Watchlist Price Alert

Mirum Pharmaceuticals Inc... (MIRM)

NASDAQ: MIRM · Real-Time Price · USD

51.10

0.54 (1.07%)

At close: Jun 27, 2025, 1:28 PM

Mirum Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Net Income	-87.94M	-163.41M	-135.66M	-83.99M	-103.27M	-52.55M	-17.35M
Depreciation & Amortization	23.63M	10.83M	3.68M	975K	623K	324K	n/a
Stock-Based Compensation	48.44M	35.02M	27.01M	23.09M	12.55M	6.07M	51K
Other Working Capital	-3.13M	-5.05M	-4.51M	-5.18M	-3.07M	-2.94M	-12K
Other Non-Cash Items	3.6M	69.26M	12.47M	-90.41M	335K	-326K	12.09M
Deferred Income Tax	n/a	n/a	-6.58M	595K	72K	n/a	n/a
Change in Working Capital	22.59M	-22.64M	-21.05M	16.98M	611K	7.12M	2.44M
Operating Cash Flow	10.32M	-70.94M	-120.14M	-132.76M	-89.08M	-39.36M	-373K
Capital Expenditures	-993K	-20.11M	-278K	-19.02M	-225K	-281K	-7.5M
Cash Acquisitions	n/a	-212.76M	-7.98M	-19M	-38.1M	127.5M	n/a
Purchase of Investments	-89.03M	-27.33M	-132.32M	-198.03M	-74.56M	-152M	n/a
Sales Maturities Of Investments	19.89M	153M	140.3M	157.6M	112.66M	24.5M	n/a
Other Investing Acitivies	-20M	-20M	7.98M	127M	38.1M	-127.5M	-11.25M
Investing Cash Flow	-90.13M	-107.2M	7.7M	48.55M	37.87M	-127.78M	-7.5M
Debt Repayment	n/a	305.3M	n/a	n/a	n/a	n/a	50K
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	17.7M	-185.39M	1.72M	66.55M	49.42M	n/a	n/a
Financial Cash Flow	17.7M	336.6M	109.09M	73.47M	181.29M	127.18M	59.84M
Net Cash Flow	-63.4M	158.32M	-3.34M	-10.75M	130.12M	-39.99M	51.96M
Free Cash Flow	9.33M	-91.05M	-120.41M	-151.78M	-89.3M	-39.64M	-7.87M